These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2917185)

  • 21. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
    Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
    J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation.
    Niiya K; Hodson E; Bader R; Byers-Ward V; Koziol JA; Plow EF; Ruggeri ZM
    Blood; 1987 Aug; 70(2):475-83. PubMed ID: 3607284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex.
    Huang TF; Holt JC; Lukasiewicz H; Niewiarowski S
    J Biol Chem; 1987 Nov; 262(33):16157-63. PubMed ID: 3680247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The platelet fibrinogen receptor: an immunogold-surface replica study of agonist-induced ligand binding and receptor clustering.
    Isenberg WM; McEver RP; Phillips DR; Shuman MA; Bainton DF
    J Cell Biol; 1987 Jun; 104(6):1655-63. PubMed ID: 3584243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets.
    Gartner TK; Bennett JS
    J Biol Chem; 1985 Oct; 260(22):11891-4. PubMed ID: 2995350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paradoxical inhibition of fibrinogen binding and potentiation of alpha-granule release by specific types of inhibitors of glycoprotein IIb-IIIa.
    Schneider DJ; Taatjes DJ; Sobel BE
    Cardiovasc Res; 2000 Jan; 45(2):437-46. PubMed ID: 10728364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ability of different glycoprotein IIb-IIIa ligands to support platelet aggregation induced by activating antibody CRC54.
    Naimushin YA; Mazurov AV
    Biochemistry (Mosc); 2005 Jul; 70(7):782-9. PubMed ID: 16097942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LDLs increase the exposure of fibrinogen binding sites on platelets and secretion of dense granules.
    van Willigen G; Gorter G; Akkerman JW
    Arterioscler Thromb; 1994 Jan; 14(1):41-6. PubMed ID: 8274476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of an RGDS binding site on the platelet membrane glycoprotein IIb-IIIa complex.
    Santoro SA; Lawing WJ
    Biochem Biophys Res Commun; 1989 Apr; 160(1):189-95. PubMed ID: 2712830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disagregin is a fibrinogen receptor antagonist lacking the Arg-Gly-Asp sequence from the tick, Ornithodoros moubata.
    Karczewski J; Endris R; Connolly TM
    J Biol Chem; 1994 Mar; 269(9):6702-8. PubMed ID: 8120028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib.
    Soslau G; Class R; Morgan DA; Foster C; Lord ST; Marchese P; Ruggeri ZM
    J Biol Chem; 2001 Jun; 276(24):21173-83. PubMed ID: 11283012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligand inhibition of the platelet glycoprotein IIb-IIIa complex function as a calcium channel in liposomes.
    Rybak ME; Renzulli LA
    J Biol Chem; 1989 Sep; 264(25):14617-20. PubMed ID: 2549026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The occupancy of glycoprotein IIb-IIIa complex modulates thrombin activation of human platelets.
    Sinigaglia F; Torti M; Ramaschi G; Balduini C
    Biochim Biophys Acta; 1989 Sep; 984(2):225-30. PubMed ID: 2548625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.
    Coller BS; Peerschke EI; Scudder LE; Sullivan CA
    J Clin Invest; 1983 Jul; 72(1):325-38. PubMed ID: 6308050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective recognition of adhesive sites in surface-bound fibrinogen by glycoprotein IIb-IIIa on nonactivated platelets.
    Savage B; Ruggeri ZM
    J Biol Chem; 1991 Jun; 266(17):11227-33. PubMed ID: 2040630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation.
    Shattil SJ; Hoxie JA; Cunningham M; Brass LF
    J Biol Chem; 1985 Sep; 260(20):11107-14. PubMed ID: 2411729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical and functional consequences of dissociation of the platelet membrane glycoprotein IIb-IIIa complex.
    Shattil SJ; Brass LF; Bennett JS; Pandhi P
    Blood; 1985 Jul; 66(1):92-8. PubMed ID: 3159447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P-selectin expression on platelets determines size and stability of platelet aggregates.
    Merten M; Thiagarajan P
    Circulation; 2000 Oct; 102(16):1931-6. PubMed ID: 11034941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colloidal gold labelling of fibrinogen receptors in epinephrine- and ADP-activated platelet suspensions.
    Oliver JA; Albrecht RM
    Scanning Microsc; 1987 Jun; 1(2):745-56. PubMed ID: 3616571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of platelet retention on artificial microvascular grafts with monoclonal antibodies and a high-affinity peptide directed against platelet membrane glycoproteins.
    Johnson PC; Sheppeck RA; Hribar SR; Bentz ML; Janosky J; Dickson CS
    Arterioscler Thromb; 1991; 11(3):552-60. PubMed ID: 1709360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.